We use cookies on this website. By continuing to use this site without changing your cookie settings, you agree that you are happy to accept our privacy policy and for us to access our cookies on your device.
Description EnglishExperts predict that psychedelic compounds could become a billion-dollar industry for treating depression and trauma after initial clinical trials in the United States show promising results. Out of respect for medical privacy some full names were not used. Aron Ranen has the story from New York City.
Brand / Language ServiceVoice of America - English